TURK ILAC VE SERUM SANAYI ANONIM SIRKETI

Turk Ilac Ve Serum Sanayi Anonim Sirketi

TRILC

TRETRLC00022

Pharmaceuticals

Market Closed - Borsa Istanbul Other stock markets 16:09:59 14/05/2024 BST			5-day change	1st Jan Change
31.02 ^TRY	+4.73%		+21.65%	+171.39%

04-04	Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.

June 07, 2022

The Board of Directors of Turk Ilac Ve Serum Sanayi Anonim Sirketi has authorized a buyback plan on June 8, 2022.

Latest news about Turk Ilac Ve Serum Sanayi Anonim Sirketi

Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	04-04	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/10/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023	02/05/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	15/02/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	14/02/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022	10/02/23	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) dropped from S&P Global BMI Index	19/09/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/08/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	08/06/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	07/06/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022	17/05/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021	18/02/22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	01/11/21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	22/09/21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	21/09/21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) added to S&P Global BMI Index	20/09/21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter Ended June 30, 2021	06/08/21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2021	30/04/21	CI

Chart Turk Ilac Ve Serum Sanayi Anonim Sirketi

Duration

Period

Chart Turk Ilac Ve Serum Sanayi Anonim Sirketi

More charts

Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.

Sector

Pharmaceuticals

Calendar

04/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TURK ILAC VE SERUM SANAYI ANONIM SIRKETI	+171.39%	149M
ELI LILLY AND COMPANY	+31.06%	682B
NOVO NORDISK A/S	+30.35%	586B
JOHNSON & JOHNSON	-3.42%	364B
MERCK & CO., INC.	+18.02%	327B
ABBVIE INC.	+4.27%	285B
ASTRAZENECA PLC	+15.53%	240B
NOVARTIS AG	+10.16%	209B
ROCHE HOLDING AG	-8.14%	203B
AMGEN INC.	+8.12%	165B